Additionally, a substantial proportion of patients exhibit primary resistance that arises from diverse mechanisms, including the inherent resistance of tumor cells to T-cell engagement, limited tumor immunogenicity, impaired CD8+ T-cell migration to the tumor site, and immune inhibitory factors, such as myeloid-derived suppressor cells (MDSCs) and Tregs, within the TME 2,111. Here, CD8A is linked to neoplasm.